Efficacy and Tolerability of Apevitin BC Comparing to Vitamin Complex in Stimulating the Appetite (Inappetence)
Multicenter Clinical Study, Phase III, Randomized, Double-blind, of Prospectively Evaluate the Effectiveness and Tolerability of Apevitin BC Comparing to Vitamin Complex in Appetite Stimulation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Design:
- Multicenter
- Phase III
- Randomized
- Double Blind
- Prospective and Comparative
- Experiment duration: 30 days
- 3 visits (day 0, day 15 and day 30)
- Increased appetite
- Adverse event
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
SP
-
Santo André, SP, Brazil
- Faculdade de Medicina do ABC
-
São Paulo, SP, Brazil
- Clínica A/Z
-
São Paulo, SP, Brazil
- Cliníca Dr. Felício Savioli
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with inappetence;
- Wash out 20 days after ingestion before similar drug;
- The charge of the patient must understand and consent in writing;
- Responsible for the minor must be able to understand the study procedures, agree to participate and give written consent.
Exclusion Criteria:
- Patients with intestinal parasitoses infection;
- Patients with glaucoma open or closure angle;
- Patients with predisposition to urinary retention;
- Patients with stenosis peptic ulcer or pylorus - duodenal obstruction;
- Debilitated patients or in acute attack of asthma;
- Patients who have lass of appetite caused by any serious disease;
- Patients who make use of any drugs central nervous system depressants;
- Patients who make use of medicines monoamineoxidase inhibitors, tricyclic antidepressants, phenothiazines, probenecid, levodopa, phenytoin, Phenobarbital, chloramphenicol, cyclosphosphamide, cyclosporine, chlorambucil,corticotropin, mercaptopurine, isoniazid , penicillin, estrogens, contraceptives, haloperidol, ipratropium, barbiturates, primidone, salicylates.
- Hypersensitivity to components of the formula
- Patients who is participating in another clinical study;
- No able to adhere to protocol;
- Any pathology or past medical condition that can interfere with this protocol.
- Other conditions deemed reasonable by the medical investigator as to the disqualification of the individual from study participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Apevitin BC
Children (5 to 6 years): 3.5 ml 3 times a daily Children (7 to 15 years): 5 ml 3 times a daily
|
3.5 to 5 ml 3 times a daily
|
|
Active Comparator: Vitamin B Complex + Vitamin C
Children (5 to 6 years): 3.5 ml 3 times a daily Children (7 to 15 years): 5 ml 3 times a daily
|
3.5 to 5 ml 3 times a daily
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the effectiveness of Apevitin BC in appetite stimulation compared to vitamin complex.
Time Frame: 30 days
|
Clinical evaluation of the patient's general condition.
The lowest responsible will report less data about their inappetence.
|
30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the tolerability of Apevitin BC in stimulating the appetite compared to vitamin complex
Time Frame: 30 days
|
The lowest responsible will repost less data about their inappetence.Final evaluation of efficacy and tolerability.
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TRPEMS0910
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.